Linked Life Data

19617851

Source:http://linkedlifedata.com/resource/pubmed/id/19617851

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2009-10-29
pubmed:abstractText
The hemostatic system is activated during cardiopulmonary bypass (CPB) procedures, and the use of heparin attenuates the coagulation. However, heparin resistance occurs in between 4 and 22% of patients undergoing cardiac surgery, and the preoperative use of heparin is usually responsible for this. Sometimes, critically ill patients are referred for intra-aortic balloon pump (IABP) insertion, and anticoagulation therapy with heparin is recommended to prevent thrombosis and embolization. The author experienced heparin resistance in patients who underwent percutaneous coronary intervention (PCI) and IABP insertion.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1558-2035
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
940-1
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Heparin resistance during cardiopulmonary bypass.
pubmed:affiliation
Department of Anesthesiology and Pain Medicine, The Catholic University of Korea, College of Medicine, Seoul, Korea.
pubmed:publicationType
Journal Article, Case Reports